TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Biotechnology CMO and CDMO Market on Track for USD 199.67 Billion by 2034 with a Strong 11.54% CAGR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
Biotechnology CMO and CDMO Market on Track for USD 199.67 Billion by 2034 with a Strong 11.54% CAGR

The global biotechnology Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) market is projected to grow from $74.01 billion in 2025 to $199.67 billion by 2034, driven by increasing demand for biologics, biosimilars, and gene therapies.

Insights
MSFT   negative

Came under pressure over rising capital expenditures and delayed return on investment


TMO   positive

Highlighted as a key market player with multiple service divisions and strong presence in viral vector and biologics manufacturing